NCT00211419View on ClinicalTrials.gov

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Maculopathy, Age-Related
Interventions
DRUG

Anecortave Acetate 15 mg

DRUG

Triamcinolone Acetate 4 mg

PROCEDURE

Photodynamic Therapy with Verteporfin

PROCEDURE

Thermal Laser

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Manhattan Eye, Ear & Throat Hospital

OTHER

NCT00211419 - Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) | Biotech Hunter | Biotech Hunter